LIVEKIDNEY.BIO

About

Headcount over time

Offices

Q&A

What is LIVEKIDNEY.BIO's primary focus?

LIVEKIDNEY.BIO is a clinical-stage biotech company developing cell-based therapies for kidney diseases, aiming to improve the health span and lifespan for kidney patients worldwide.

When was LIVEKIDNEY.BIO founded?

LIVEKIDNEY.BIO was founded in 2013.

What is LIVEKIDNEY.BIO's employee count?

LIVEKIDNEY.BIO has 1-10 employees.

What is the total amount of funding LIVEKIDNEY.BIO has raised to date?

LIVEKIDNEY.BIO has raised a total of $9,000,000 USD.

When did LIVEKIDNEY.BIO complete its most recent funding round?

LIVEKIDNEY.BIO completed a Seed funding round in November 2023, raising $4,000,000 USD.

What technology does LIVEKIDNEY.BIO utilize in its products?

LIVEKIDNEY.BIO's products are based on proprietary, cell-shielding formulations of mesenchymal stromal cells (MSCs) and utilize a proprietary delivery platform with biodegradable hydrogel formulations for cell therapies, combined with AI-enabled data analytics.

What is the current product stage of LIVEKIDNEY.BIO?

LIVEKIDNEY.BIO is in the clinical trial product stage.

Who is the CEO and Co-Founder of LIVEKIDNEY.BIO?

Alon Yaar is the CEO and Co-Founder of LIVEKIDNEY.BIO.

Team · 12

Dr. Alon Yaar

Founder · CEO

Jonathan Leitersdorf

Founder · Angel Investor and Founder

Roy Golan

Finance Leader

Dr. Masha Simanovsky

R&D Leader

Dr. Shimon Amselem

Technology Leader

Dr. Nadya Lisovoder

Clinical Leader

Miri Sani

Regulatory Affairs Leader

Prof. Chaim Putterman

Advisory Board Member

Prof. Lilach O. Lerman

Advisory Board Member

Prof. Gary Gilkeson

Advisory Board Member

Dr. Shimon Aronhime

Advisory Board Member

Eli Gelman

Advisory Board Member

Sectors & technology

Highlights

Tags